20.5 C
New York
Sunday, June 7, 2026

Tag: stages

newssourceFORcompanyinformationcontent1marketreleases

LGI Homes Celebrates National Homeownership Month

LGI Homes proudly recognizes National Homeownership Month, an annual celebration highlighting the lasting impact homeownership has on families.

China’s Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and...

China’s Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and...

Notice of Annual General Meeting 2026

Oslo, 5 June 2026 – DNO ASA, the Norwegian oil and gas operator, today announced that the Annual General Meeting scheduled for 26 June 2026 will be held as a digital meeting at 10:00 Norwegian time. Shareholders can vote at the meeting, in advance or by proxy. 

Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR

The study showed that orelabrutinib was safe and well tolerated in participants with SLE.

Mabwell’s 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease

SHANGHAI, June 4, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently developed innovative...

WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility

SINGAPORE, June 4, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has completed the...

RØZ ANNOUNCES HEADLINING MONSTER ENERGY OUTBREAK TOUR KICKING OFF 10/21

Presale Tickets Tuesday 6/9 at 10AM LocalCORONA, Calif., June 4, 2026 /PRNewswire/ -- Rapidly rising Mexican electronic artist and producer duo RØZ have announced that...

MemeToro AI Agent Presale Gains Momentum as BNB Hack $36K Prize Looms

BNB Chain's $36K AI trading agent hackathon spotlights autonomous crypto tools, putting MemeToro ($MT) and its AI-agent presale in sharper focus. 
BNB Chain's $36K AI trading agent hackathon spotlights autonomous crypto tools, putting MemeToro ($MT) and its AI-agent presale in sharper focus.

Minister Hajdu and industry leaders launch the Mining and Minerals Workforce Alliance

WESTERN SHORE, NS, June 4, 2026 /CNW/ - As Canada's labour market continues to face sustained pressures from tariffs, skills shortages, supply chain disruptions,...

Sportradar Nets Official Wimbledon Tennis Data and AV Betting Rights Deal

ST. GALLEN, Switzerland and LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ: SRAD), a leading global sports technology company creating immersive experiences for sports fans and bettors, today announced a multi-year extension of its data and audiovisual (AV) betting rights agreement for The Championships, Wimbledon. The rights were originally secured as part of the company’s acquisition of IMG ARENA in 2025.

AbolerIS Pharma Presents New Data Supporting CD45RC as a Novel Therapeutic Target and Potential Biomarker in Sjögren’s Disease at EULAR 2026

- Findings demonstrate strong correlation between CD45RC expression and lymphocytic infiltration in salivary glands, supporting its potential as both an early biomarker and therapeutic...

GetGo Smashes $100,000 Car Ownership Burden in Campaign for Sustainable Mobility

With Category A COE prices exceeding S$100,000, GetGo stages a car smash to make the case for sustainable, commitment-free access to driving.SINGAPORE, June 4,...

POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding

Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S. 
Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStages

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers